Next week, Amsterdam becomes the global hub for rare disease innovation at the World Orphan Drug Congress.
In less than one week, our CEO, Geert Briers, will head to Amsterdam to connect with leaders shaping the future of orphan disease care.
Our key focus: clinical trial home visits.
For patients with rare conditionsâoften living far from specialized hospitalsâhome visits are more than convenience. Theyâre a lifeline. By bringing research directly to the patient, we reduce travel burdens, improve trial accessibility, and support better outcomes.
At Deltaclinical, we believe that decentralized trials are essential to making research more inclusive and compassionate. Letâs keep pushing boundaries for those who need it most.